Double Moving Average Crossover
Previous Close | 28.47 |
Open | 28.47 |
Bid | 27.71 x 800 |
Ask | 28.54 x 800 |
Day's Range | 28.29 - 29.25 |
52 Week Range | 21.83 - 39.78 |
Volume | |
Avg. Volume | 932,212 |
Market Cap | 3.283B |
Beta (5Y Monthly) | 1.55 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.37 |
Earnings Date | Jul 31, 2023 - Aug 04, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 47.25 |
Key Insights Evolent Health's estimated fair value is US$57.93 based on 2 Stage Free Cash Flow to Equity Evolent Health...
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Executive Officer Seth Blackley, Chief Financial Officer John Johnson and Vice President, Investor Relations Seth Frank will participate in upcoming investor conferences, including meetings with institutional investors and presentations.
With a median price-to-sales (or "P/S") ratio of close to 2.3x in the Healthcare Services industry in the United...
Q1 2023 Evolent Health Inc Earnings Call
Welcome to Evolent Health's earnings conference call for the quarter ended March 31st, 2023. Your host for the call today from Evolent Health are Seth Blackley, chief executive officer; and John Johnson, chief financial officer.
Evolent Health (EVH) delivered earnings and revenue surprises of 40% and 1.81%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter ended March 31, 2023.
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven specialty clinical solutions to payers and providers, today announced that a new director nominee will stand for election to the Board of Directors at the annual meeting of stockholders scheduled to be held on June 8, 2023.
Evolent Health, Inc. ( NYSE:EVH ) is possibly approaching a major achievement in its business, so we would like to...
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven specialty clinical solutions to payers and providers, today announced it will release its first quarter 2023 financial results on Wednesday, May 3, 2023, after market close, with a conference call to follow at 5 p.m. ET.
Centene (CNC) expands the use of Evolent's oncology specialty care to improve cost management.
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers, today announced an agreement to expand its Technology and Services solution for oncology with its existing partner, Centene Corporation, (NYSE: CNC).
Evolent Health, Inc. ( NYSE:EVH ) shareholders might be concerned after seeing the share price drop 12% in the last...
Evolent Health ( NYSE:EVH ) Full Year 2022 Results Key Financial Results Revenue: US$1.35b (up 49% from FY 2021). Net...
Evolent Health Inc (NYSE: EVH) reported Q4 adjusted EPS of $0.10, missing the consensus of $0.16, compared to $0.08 a year ago. Revenues increased 54% Y/Y to $382.43 million, beating the consensus of $372.93 million. Total Lives on the Platform of 20.6 million as of Dec. 31, 2022, compared to 17.7 million a year ago. Total cases managed during the quarter within surgical management and advanced care planning totaled 15.7k, yielding an average per case revenue of $2.8k. Guidance: Evolent Health s
Welcome to Evolent Health's earnings conference call for the fourth quarter and year ended December 31, 2022. Your host for the call today from Evolent Health are Seth Blackley, chief executive officer; and John Johnson, chief financial officer.
Evolent Health (EVH) delivered earnings and revenue surprises of 66.67% and 2.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter ended December 31, 2022.
EngageSmart (ESMT) delivered earnings and revenue surprises of 0% and 3.08%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. Small-cap stocks posted solid returns in the fourth quarter for the first time in 2022. The Russell 2000 Growth Index was up 4.11% trailing the Russell 2000 […]
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced it will release its fourth quarter 2022 financial results on Wednesday, February 22, 2023 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.
With the deal's close, Clayton-based health care giant Centene launches a multiyear partnership with Virginia-based Evolent Health.
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
While Evolent Health, Inc. ( NYSE:EVH ) might not be the most widely known stock at the moment, it received a lot of...
Does the December share price for Evolent Health, Inc. ( NYSE:EVH ) reflect what it's really worth? Today, we will...